Key result
Patients with familial Legg-Calvé-Perthes disease exhibited significant hemostatic alterations, including differences in hemoglobin, fibrinogen, and factor IX activity (p ≤ 0.0001) compared to healthy controls.
Why the study?
The etiology of Legg-Calvé-Perthes disease is not fully understood, but evidence suggests heritable thrombotic disorders and other factors may be implicated in its onset and progression.
Are genetic, biochemical, and environmental factors associated with the etiology and development of Legg-Calvé-Perthes disease in familial cases?
Case-Control (n=21)
No
Are genetic, biochemical, and environmental factors associated with the etiology and development of Legg-Calvé-Perthes disease in familial cases?
p-value: p=≤0.0001
Familial cases of Legg-Calvé-Perthes disease in a Mexican cohort are associated with hemostatic disorders, elevated homocysteine, and the MTHFR C677T polymorphism, suggesting a multifactorial prothrombotic etiology.
Supports hemostatic evaluation in familial Legg-Calvé-Perthes; hypothesis-generating and should not yet change practice.
BackgroundLegg-Calvé-Perthes Disease (LCPD) is described as an avascular necrosis of the femoral head. Although its etiology is still not fully understood, evidences suggest heritable thrombotic disorders and other factors may be implicated in its onset and progress. Our objective is to describe, in three enrolled families, the genetic, biochemical and environmental factors that may be associated with the etiology and development of LCPD. MethodsTherefore, we set out to evaluate the following alterations of collagen genes: MTHFR rs1801133, CBS rs115742905, and PT rs1799963 and their relationship with LCPD. Thrombophilia associated markers (FI, FII, FV, FVII, FVIII, FIX, FX, FXI, FXII, FvW, PC, PS, AT, and homocysteine) were evaluated using coagulometry methods. Results: Seven LCPD patients and 14 healthy volunteers were enrolled. Concentrations in hemoglobin (p ≤ 0.0001), fibrinogen (P ≤ 0.0001), homocysteine (p = 0.0414), factor IX activity percentage (p ≤ 0.0001), and protein S (p = 0.0478) showed statistically significant differences. None of the evaluated polymorphisms showed statistically significant differences. However, all patients presented the mutated MTHFR C677T polymorphism in a homozygous (T/T) or heterozygous manner (C/T).ConclusionsOur results show environmental elements from every family and hemostatic disorders may be involved in suffering and developing LCPD. Also, heritable factors could contribute to the onset of the disease. Clearly, environmental, genetic, and prothrombotic factors are involved in this pathology.
No takes yet. Share an insight, caveat, or question.
Rodríguez-Olivas et al. (2021) conducted a case-control in Legg-Calvé-Perthes disease (n=21). Hemostatic and genetic alterations vs. Healthy volunteers was evaluated on Differences in hemostatic markers (hemoglobin, fibrinogen, homocysteine, factor IX, protein S) (p=≤0.0001). Patients with familial Legg-Calvé-Perthes disease exhibited significant hemostatic alterations, including differences in hemoglobin, fibrinogen, and factor IX activity (p ≤ 0.0001) compared to healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: